Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Pyxis Oncology Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a 376.19% increase from the last price of 2.10.
High | 471.4% | 12.00 |
Med | 376.2% | 10.00 |
Low | 233.3% | 7.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 19, 2025.
Average growth rate | -70.28% |
Average growth rate | +54.27% |
More ▼
Revenue history & estimates in USD
Average growth rate | -33.33% |
Average growth rate | 0.00% |
More ▼